Lonza Group Ag Pre-Tax Income 2012-2023 | LZAGY
Lonza Group Ag annual/quarterly pre-tax income history and growth rate from 2012 to 2023. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Lonza Group Ag pre-tax income for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Lonza Group Ag pre-tax income for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Lonza Group Ag annual pre-tax income for 2023 was $0.88B, a 42.01% decline from 2022.
- Lonza Group Ag annual pre-tax income for 2022 was $1.517B, a 82.48% increase from 2021.
- Lonza Group Ag annual pre-tax income for 2021 was $0.832B, a 2.91% decline from 2020.
| Lonza Group Ag Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2023 | $880 |
| 2022 | $1,517 |
| 2021 | $832 |
| 2020 | $856 |
| 2019 | $855 |
| 2017 | $590 |
| 2016 | $379 |
| 2015 | $355 |
| 2014 | $305 |
| 2013 | $113 |
| 2012 | $236 |
| 2011 | $198 |
| Lonza Group Ag Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $45.437B | $7.478B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.879B | 25.82 |
| Stryker (SYK) | United States | $137.705B | 32.18 |
| Boston Scientific (BSX) | United States | $121.595B | 37.03 |
| Medtronic (MDT) | Ireland | $113.026B | 16.82 |
| EssilorLuxottica (ESLOY) | France | $104.378B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.118B | 35.17 |
| ResMed (RMD) | United States | $34.974B | 30.79 |
| Koninklijke Philips (PHG) | Netherlands | $29.016B | 22.05 |
| Terumo (TRUMY) | Japan | $27.876B | 39.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.644B | 13.63 |
| Baxter (BAX) | United States | $20.086B | 13.62 |
| Insulet (PODD) | United States | $16.555B | 69.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.426B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.489B | 31.44 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.672B | 32.44 |
| Lantheus Holdings (LNTH) | United States | $7.508B | 18.02 |
| ICU Medical (ICUI) | United States | $4.304B | 41.08 |
| TG Therapeutics (TGTX) | United States | $3.909B | 41.39 |
| Haemonetics (HAE) | United States | $3.870B | 19.14 |
| Perrigo (PRGO) | Ireland | $3.841B | 12.14 |
| GN Store Nord (GNNDY) | Denmark | $3.758B | 22.64 |
| Neogen (NEOG) | United States | $3.736B | 39.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.644B | 18.16 |
| Envista Holdings (NVST) | United States | $3.298B | 17.60 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.591B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.311B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.171B | 36.43 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 53.20 |
| AdaptHealth (AHCO) | United States | $1.524B | 11.00 |
| InMode (INMD) | Israel | $1.466B | 9.34 |
| Warby Parker (WRBY) | United States | $1.466B | 0.00 |
| AtriCure (ATRC) | United States | $1.363B | 0.00 |
| Owens & Minor (OMI) | United States | $1.219B | 9.41 |
| Verano Holdings (VRNOF) | United States | $1.114B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.094B | 0.00 |
| Evolus (EOLS) | United States | $1.023B | 0.00 |
| PetIQ (PETQ) | United States | $0.920B | 23.32 |
| Phibro Animal Health (PAHC) | United States | $0.897B | 18.61 |
| National Vision Holdings (EYE) | United States | $0.864B | 27.48 |
| Cresco Labs (CRLBF) | United States | $0.801B | 0.00 |
| Surmodics (SRDX) | United States | $0.561B | 119.09 |
| Quanterix (QTRX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.454B | 42.23 |
| VAREX IMAGING (VREX) | United States | $0.451B | 13.62 |
| Valneva SE (VALN) | France | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.406B | 0.00 |
| Jin Medical (ZJYL) | China | $0.397B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.333B | 0.00 |
| Cerus (CERS) | United States | $0.330B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.321B | 8.29 |
| Aurora Cannabis (ACB) | Canada | $0.320B | 0.00 |
| Biote (BTMD) | United States | $0.319B | 14.70 |
| Viemed Healthcare (VMD) | United States | $0.287B | 30.79 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Zynex (ZYXI) | United States | $0.260B | 45.44 |
| Utah Medical Products (UTMD) | United States | $0.234B | 15.52 |
| Ayr Wellness (AYRWF) | United States | $0.232B | 0.00 |
| Omeros (OMER) | United States | $0.228B | 0.00 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 70.33 |
| Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
| Brainsway (BWAY) | Israel | $0.140B | 168.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.124B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 24.20 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.056B | 3.63 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Bright Green (BGXX) | United States | $0.028B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Agape ATP (ATPC) | $0.008B | 0.00 | |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.47 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |